Related Experiment Video
Updated: Jul 26, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Serological diagnosis of autoimmune hepatobiliary diseases
Khalil Abdul-Aziz1, Abdul-Aziz Faizal
1Regional Department of Immunology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom. khalilazizh@yahoo.co.uk
Insights
Autoimmune hepatobiliary diseases (AIHBD) require early diagnosis via serological tests. Understanding autoantibody test results is crucial for timely intervention and preventing severe outcomes.
Area of Science:
- Hepatology
- Clinical Immunology
- Autoimmunology
Background:
- Autoimmune hepatobiliary diseases (AIHBD) encompass autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis.
- Untreated AIHBD are associated with significant morbidity and mortality.
- Early diagnosis and treatment are critical for improved patient outcomes.
Purpose of the Study:
- To review serological tests used for AIHBD screening.
- To explain the significance of autoantibody test results in diagnosing AIHBD.
- To promote earlier and more efficient diagnosis and treatment of AIHBD.
Main Methods:
- Review of diagnostic tests available in clinical immunology laboratories.
- Discussion of serum autoantibodies associated with AIHBD.
- Analysis of the clinical significance of test results.
Main Results:
- Serological tests detecting specific autoantibodies are key for AIHBD screening.
- Interpretation of autoantibody profiles aids in disease diagnosis and exclusion.
- Understanding test results facilitates efficient clinical decision-making.
Conclusions:
- Accurate interpretation of autoantibody tests is vital for managing AIHBD.
- This review aims to enhance understanding and improve diagnostic efficiency for AIHBD.
- Earlier diagnosis and treatment can mitigate the severe consequences of AIHBD.
Abstract:
Autoimmune hepatobiliary diseases AIHBD comprise autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis and the overlap syndromes. Early diagnosis and treatment of AIHBD are essential for the prevention of the high morbidity, and mortality, that is, otherwise, associated with untreated patients. Screening for AIHBD relies heavily on the use of serological tests for the detection of serum autoantibodies that associate with the diseases. Understanding these tests, and the results produced, is important for the efficient diagnosis/exclusion of these diseases. In this review, we discuss the various tests available in the clinical immunology laboratory for screening of AIHBD and comment on the significance of the results produced by each test. We hope that this review will highlight this group of autoimmune diseases and lead to more efficient and earlier diagnosis, and treatment, of patients with AIHBD.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction